Abstract:Foxp3(+) CD4(+) regulatory T (Treg) cells, recognized to be one of the most important defences of the human body against an inappropriate immune response, have recently gained attention from those outside immunology thanks to the compelling evidence for their capability to exert non-canonical immune functions in a variety of tissues in health and disease. The recent discovery of the differences between tissue-resident Treg cells and those derived from lymphoid organs is affecting the mindset of many investigators now questioning the broad applicability of observations originally based on peripheral blood/lymphoid organ cells. So far, the best characterized 'Treg flavour' comes from studies focused on their role in suppressing adipose tissue inflammation and obesity-driven insulin resistance. Adipose tissue derived Treg cells are distinct from their counterparts in lymphoid organs based on their transcriptional profile, T-cell receptor repertoire, and cytokine and chemokine receptor expression pattern. These cells are abundant in visceral adipose tissue of lean mice but their number is greatly reduced in insulin-resistant animal models of obesity. Interestingly, peroxisome-proliferator-activated receptor γ expression by visceral adipose tissue Treg cells is crucial for their accumulation, phenotype and function in the fat and surprisingly necessary for complete restoration of insulin sensitivity in obese mice by the anti-diabetic drug Pioglitazone. This review surveys recent findings relating to the unique phenotype and function of adipose tissue-resident Treg cells, speculates on the nature of their dynamics in lean and obese mouse models, and analyses their potential therapeutic application in the treatment of type 2 diabetes.

Adipose tissue-resident regulatory T cells: phenotypic specialization, functions and therapeutic potential

A Unique Population: Adipose-Resident Regulatory T Cells.

Adipose tissue regulatory T cells: differentiation and function

Tissue adaptation of regulatory T cells in adipose tissue

Tissue resident regulatory T cells: novel therapeutic targets for human disease

Adipose-tissue Regulatory T Cells Are a Consortium of Subtypes That Evolves with Age and Diet.

Adipose Tissue-Resident Immune Cells in Obesity and Type 2 Diabetes

Research Progress of Regulatory T Cells in Visceral Adipose Tissue

Insulin signaling establishes a developmental trajectory of adipose regulatory T cells

Deciphering visceral adipose tissue regulatory T cells: Key contributors to metabolic health

Antigen- and cytokine-driven accumulation of regulatory T cells in visceral adipose tissue of lean mice

Interferon-α-producing Plasmacytoid Dendritic Cells Drive the Loss of Adipose Tissue Regulatory T Cells During Obesity

Tissue Tregs and Maintenance of Tissue Homeostasis

Regulatory T Cells: the Many Faces of Foxp3

Pleiotropic adipose Treg subsets, defined by Atf3 expression, modulate adipocyte energy expenditure and weight loss

Adipose T reg cells in charge of metabolism

Resident and migratory adipose immune cells control systemic metabolism and thermogenesis

Adipose-tissue Treg Cells Restrain Differentiation of Stromal Adipocyte Precursors to Promote Insulin Sensitivity and Metabolic Homeostasis

Distinct immunocyte-promoting and adipocyte-generating stromal components coordinate adipose tissue immune and metabolic tenors

Deciphering the developmental trajectory of tissue-resident Foxp3+ regulatory T cells

Adipocyte subpopulations mediate lipolysis and obesity induced insulin resistance